
Sign up to save your podcasts
Or


From updates in combination therapy to developments in novel agents, Dr. Daniel Persky shares what he expects to see for chronic lymphocytic leukemia and mantle cell lymphoma from the American Society of Hematology’s 63rd Annual Meeting and Exposition.
By ReachMD4.5
22 ratings
From updates in combination therapy to developments in novel agents, Dr. Daniel Persky shares what he expects to see for chronic lymphocytic leukemia and mantle cell lymphoma from the American Society of Hematology’s 63rd Annual Meeting and Exposition.

39 Listeners

10 Listeners

59 Listeners

1,145 Listeners

195 Listeners

45 Listeners

7 Listeners